The Eye, Ear, Nose and Throat Hospital of Fudan University, formerly the Shanghai Jewish Hospital, is a teaching hospital in Shanghai, China, affiliated with the Shanghai Medical College of Fudan University and the Red Cross Society of Shanghai.

During the past decade, Eye & ENT Hospital of Fudan University conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Eye & ENT Hospital of Fudan University" #1 sponsor was "Eye & ENT Hospital of Fudan University" with 32 trials, followed by "Chengdu Kanghong Biotech Co., Ltd." with 6 trials sponsored, "Evidence Based Cataract Study Group" with 3 trials sponsored, "Shanghai BDgene Co., Ltd." with 2 trials sponsored and "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eye & ENT Hospital of Fudan University" #1 collaborator was "Eye & ENT Hospital of Fudan University" with 9 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 4 trials as a collaborator, "Xinhua Hospital, Shanghai Jiao Tong University School of Medicine" with 4 trials as a collaborator, "Children's Hospital of Fudan University" with 3 trials as a collaborator and "Shandong Provincial Hospital" with 3 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Eye & ENT Hospital of Fudan University" are "Cataract" (5 trials), "Neovascular Age-related Macular Degeneration" (4 trials), "High Myopia" (3 trials), "Nasopharyngeal Carcinoma" (3 trials) and "Recurrent Nasopharyngeal Carcinoma" (3 trials). Many other conditions were trialed in "Eye & ENT Hospital of Fudan University" in a lesser frequency.

Most popular intervention types in "Eye & ENT Hospital of Fudan University" are "Drug" (36 trials), "Procedure" (15 trials), "Device" (7 trials), "Other" (7 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "endoscopic surgery" (4 trials), "Ranibizumab" (3 trials), "Camrelizumab" (2 trials), "Capecitabine" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Eye & ENT Hospital of Fudan University" are 63 trials for "All" genders.

Currently, there are NaN active trials in "Eye & ENT Hospital of Fudan University". undefined are not yet recruiting, 24 are recruiting, 2 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 13 completed trials in Eye & ENT Hospital of Fudan University, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eye & ENT Hospital of Fudan University, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 24 trials that are defined as “Not Applicable".